mitomycin has been researched along with sym-trinitrobenzene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimm, EA; Wilson, DJ | 1 |
| Lu, LJ; Wan, WH; Wang, LM | 1 |
2 other study(ies) available for mitomycin and sym-trinitrobenzene
| Article | Year |
|---|---|
The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral blood lymp
Topics: Humans; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Lymphocytes; Mitomycin; Mitomycins; Neoplasms; Nitrobenzenes; T-Lymphocytes, Cytotoxic; Trinitrobenzenes | 1985 |
[A bispecific monoclonal antibody with versatile adaptor mediating different cytotoxicities].
Topics: Animals; Antibodies, Monoclonal; Doxorubicin; Haptens; Humans; Hybridomas; Immunotoxins; Mice; Mice, Inbred BALB C; Mitomycin; Ricin; Serum Albumin, Bovine; Stomach Neoplasms; Trinitrobenzenes; Tumor Cells, Cultured | 1994 |